ECT Clinical Trials in Guangzhou, Guangdong

188 recruitingGuangzhou, Guangdong, China

Showing 120 of 188 trials

Recruiting
Not Applicable

Watch and Wait in PD-1 Monoclonal Antibody Treated dMMR/MSI-H Distal Rectal Cancer

Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University47 enrolled1 locationNCT04643041
Recruiting
Phase 1

A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

Carcinoma, Non-Small Cell LungGastroesophageal Junction AdenocarcinomaStomach Neoplasms+3 more
Seagen, a wholly owned subsidiary of Pfizer914 enrolled44 locationsNCT06131840
Recruiting

Validation of High-Throughput Large-Format Tissue Preprocessing for Lung and Colorectal Cancer

Lung Cancer (Diagnosis)CRC (Colorectal Cancer)
Nanfang Hospital, Southern Medical University1,000 enrolled1 locationNCT07239063
Recruiting
Phase 1Phase 2

Clinical Study of HRS-8080 in Combination With Dalpiciclib Isethionate Tablets in Patients With Unresectable or Metastatic Breast Cancer

Unresectable or Metastatic Breast Cancer
Shandong Suncadia Medicine Co., Ltd.146 enrolled2 locationsNCT06167694
Recruiting
Phase 3

mFOLFOX6 + Bevacizumab + PD-1 Monoclonal Antibody Vs. mFOLFOX6 in Locally Advanced pMMR/MSS CRC

Colorectal Cancer (CRC)pMMR/MSS Adenocarcinoma of the Colon or Rectum
Jun Huang166 enrolled1 locationNCT06791512
Recruiting

A Study to Explore the Early Subjective Evaluation and Objective Recovery in Lung Cancer Patients Undergoing Sublobar Resection Versus Lobectomy

Lung Cancer (Diagnosis)Sublobar ResectionLobectomy
The First Affiliated Hospital of Guangzhou Medical University300 enrolled1 locationNCT07288710
Recruiting
Phase 2

Cetuximab and Envafolimab Plus mFOLFOXIRI as First-line Treatment for RAS/BRAF Wild-type, MSS, Unresectable Left-side Metastatic Colorectal Cancer

Metastatic Colorectal Cancer
Sun Yat-sen University198 enrolled3 locationsNCT05959356
Recruiting
Phase 1

A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Cancer and Other Solid Tumors

Colorectal, CancerEsophageal CancerPancreatic Cancer+2 more
Sichuan Baili Pharmaceutical Co., Ltd.20 enrolled1 locationNCT06500052
Recruiting
Phase 1

A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies

Non-Small Cell Lung Cancer, Colorectal Cancer, Renal Cell Carcinoma, Melanoma and Other Solid Tumor
Shanghai Junshi Bioscience Co., Ltd.214 enrolled13 locationsNCT06839105
Recruiting
Phase 3

Omitting CTV for Primary Tumor in LS-SCLC

Radiotherapy Side EffectProgressionSCLC, Limited Stage+1 more
Sun Yat-sen University852 enrolled2 locationsNCT07008716
Recruiting
Phase 2

Modified Long-Course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for MSS/pMMR High-risk Mid/Low LARC (MODIFI-RC-I)

Rectal CancerRadiotherapyNeoadjuvant Therapies+1 more
Sixth Affiliated Hospital, Sun Yat-sen University80 enrolled1 locationNCT06923345
Recruiting
Phase 1Phase 2

Phase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation

Colorectal, CancerNon-small Cell Lung CancerKRAS P.G12C+1 more
Allist Pharmaceuticals, Inc.240 enrolled27 locationsNCT05288205
Recruiting

Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath

Lung CancerLung InfectionCOPD+13 more
ChromX Health10,000 enrolled1 locationNCT06528418
Recruiting
Phase 1Phase 2

A Phase Ib/II Study Confirmed Inhibition of Autophagy Synergizes Anti-tumor Effect of High Dose CDK4/6i

Inhibition of Autophagy Synergizes Anti-tumor Effect
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University29 enrolled1 locationNCT05953350
Recruiting
Phase 3

Adjuvant PD-1 Blockade for High-risk Stage-II DMMR/MSI-H Colorectal Cancer

Colorectal, CancerMicrosatellite Instability High
Sun Yat-sen University180 enrolled1 locationNCT06520683
Recruiting
Phase 2

Cetuximab, Irinotecan, Toripalimab in RAS/BRAF Wild-type Ultraselected Right-sided Colorectal Cancer Study

Colorectal Cancer Metastatic
Sun Yat-sen University34 enrolled1 locationNCT06547203
Recruiting
Phase 1Phase 2

Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors

Breast CancerLiver CancerColorectal, Cancer+8 more
Second Affiliated Hospital of Guangzhou Medical University100 enrolled1 locationNCT05187338
Recruiting

Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA Sequencing

Breast CancerLiver CancerColorectal, Cancer+5 more
Air Force Military Medical University, China3,200 enrolled8 locationsNCT06036563
Recruiting
Phase 1

A Phase I Clinical Study of QLC1101 in Patients With Advanced Solid Tumors

Colorectal, CancerPancreatic CancerNon-small Cell Lung Cancer+1 more
Qilu Pharmaceutical Co., Ltd.250 enrolled5 locationsNCT06403735
Recruiting
Phase 2

Maintenance Tislelizumab + Capecitabine to Treat Metastatic Colorectal Cancer

Metastatic Colorectal Cancer,NED
Yanhong Deng52 enrolled1 locationNCT05360277